Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04323748
What this trial is testing

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura
New York Medical College 20
Large-scale testing (Phase 3)WithdrawnNCT02767232
What this trial is testing

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

Who this might be right for
Deep Vein ThrombosisPost-Thrombotic SyndromeVenous Thrombosis
University of Colorado, Denver
Not applicableUnknownNCT04359576
What this trial is testing

Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers

Who this might be right for
Frozen Embryo Transfer
Horsens Hospital 50
Not applicableUnknownNCT03377439
What this trial is testing

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 400
Not applicableUnknownNCT06180785
What this trial is testing

Performance Evaluation of the Biological Diagnosis of HIT

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
University Hospital, Strasbourg, France 894
Not applicableLooking for participantsNCT06385353
What this trial is testing

DVT Burden and the Risk of Post-thrombotic Syndrome

Who this might be right for
Postthrombotic Syndrome
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 400
Testing effectiveness (Phase 2)Looking for participantsNCT07707687
What this trial is testing

Safety and Efficacy of Eculizumab in High-risk TA-TMA

Who this might be right for
Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
First Affiliated Hospital of Zhejiang University 24
Not applicableStudy completedNCT00736008
What this trial is testing

Thrombophilic Risk Factors in Pediatric Patients Diagnosed at the Ha'Emek Medical Center

Who this might be right for
Thrombosis
HaEmek Medical Center, Israel 100
Not applicableStudy completedNCT05005598
What this trial is testing

Long-term Venous Catheterization in Pediatric Anesthesia: Prevalence and Risk Factors of Dysfunction

Who this might be right for
Catheter Dysfunction
Central Hospital, Nancy, France 381
Not applicableStudy completedNCT06694779
What this trial is testing

Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study

Who this might be right for
Diffuse Large B Cell LymphomaThrombosis
Fondazione IRCCS San Gerardo dei Tintori 1,504
Large-scale testing (Phase 3)Not Yet RecruitingNCT07252544
What this trial is testing

Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)

Who this might be right for
Stroke, LacunarStroke, Acute IschemicCerebral Small Vessel Diseases
Beijing Tiantan Hospital 3,156
Not applicableLooking for participantsNCT06026436
What this trial is testing

Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome

Who this might be right for
Chronic Kidney Disease stage3
Assistance Publique Hopitaux De Marseille 850
Large-scale testing (Phase 3)Study completedNCT02504216
What this trial is testing

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Who this might be right for
Peripheral Artery Disease
Bayer 6,564
Not applicableStudy completedNCT01779401
What this trial is testing

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

Who this might be right for
Coronary Heart Disease
Chinese Academy of Medical Sciences, Fuwai Hospital 1,078
Not applicableStudy completedNCT00603148
What this trial is testing

The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications

Who this might be right for
Genetic Polymorphism
Vanderbilt University 475
Post-approval studies (Phase 4)Study completedNCT04418479
What this trial is testing

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Who this might be right for
Coronary Artery Disease
Joo-Yong Hahn 5,506
Not applicableUnknownNCT04949698
What this trial is testing

Risk Factors and the Effect of Plasma Exchange on Prognosis of Pregnancy-related Thrombotic Microangiopathies

Who this might be right for
Pregnancy-related Thrombotic Microangiopathies
Peking University Third Hospital 50
Early research (Phase 1)Study completedNCT01707394
What this trial is testing

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

Who this might be right for
Thromboembolism
Bristol-Myers Squibb 49
Post-approval studies (Phase 4)Study completedNCT01166685
What this trial is testing

Safety and Efficacy Study Comparing 3 New Types of Coronary Stents

Who this might be right for
Coronary Artery DiseaseCoronary Thrombosis
University Hospital, Basel, Switzerland 2,291
Not applicableUnknownNCT04596501
What this trial is testing

Exercise Training and Thrombotic Risk in Post-menopausal Women

Who this might be right for
ThrombosisMenopauseExercise Training+1 more
University of Copenhagen 30
Next Page